 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Veeva Systems Inc. (VEEV) provides cloud software and data solutions for the life sciences industry.
The company offers Veeva CRM family of applications for multichannel customer relationship management applications that allow pharmaceutical and biotechnology companies to market and sell compliantly to physicians, other healthcare professionals, and healthcare organizations through multiple touch points, including in-person, email, and online; and Veeva Vault, a cloud-based content and information management solution that enables the management of content-centric processes in various commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, and quality.
It also provides Veeva Network master data management solutions for the management of customer master and product master data.
In addition, the company offers data and data services, such as Veeva OpenData Customer Data, Compliance Data, Data Services, and Email Services for customer reference data, as well as Veeva KOL Data and services for various opinion leader data.
Further, it provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services, such as outsourced systems administration.
Shares have formed a bullish "cup and handle" following its recent quarterly report. Shares are now trading above their 50-day moving average. The company reported revenues of $142.78 million, Net Earnings of $21.63 million. Gross margins rose to 69.24% from a year-ago of 65.38%. Higher share prices are expected for this stock.
52-Weeks Trading Range: $19.97 - $47.95
Entry Point: $42.80
Stop Loss: $40.30
Target Price: $46.85
VEEV closed at $43.25
